A study of the efficacy and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in NSCLC D. Choi,H. A. Jung, S. Park,J-M. Sun,J. S. Ahn,M-J. Ahn,S-H. LeeANNALS OF ONCOLOGY(2023)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要